 Inhibition hepatic glucose production SDZ new oral hypoglycemic agent SDZ nondiabetic rats rat model human non-insulin-dependent diabetes mellitus Diabetes single injection mg/kg streptozocin rats hyperglycemia fed state normal insulin levels Treatment nondiabetic animals mg/kg SDZ serum glucose ketone levels insulin levels Nonesterified fatty acids twofold period effect ketone fatty acid levels SDZ acts inhibitor fatty acid oxidation Diabetic rats SDZ significant acute hypoglycemic response pronounced days treatment compound serum cholesterol triglyceride levels endogenous hepatic glucose production nondiabetic diabetic animals continuous infusion glucose hepatic glucose production diabetic control animals diabetic rats mg/kg SDZ hepatic glucose production normal levels Hyperinsulinemic-euglycemic clamp studies SDZ effect insulin-stimulated glucose utilization Measurement oleate oxidation isolated hepatocytes SDZ long-chain fatty acid oxidation concentration-dependent manner compound ineffective long-chain fatty acid oxidation epitrochlearis soleus muscles